Forward P/S Multiple: Treace Medical Concepts, Inc. (TMCI)
The potential of Treace Medical Concepts (TMCI) is based on physician training for the Lapiplasty system and FDA approvals. The trend in expected P/S confirms this trajectory, with the latest value recorded as 1.70. However, patent protection and stringent qualification requirements create high barriers to entry. At the same time, the rapid market capture via innovative foot correction methods carries the risk of overpaying for future sales.
Summary analytical data breakdowns for Treace Corp (TMCI)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- debt and liquidity data:
Total Debt to Capital Treace Medical Concepts|TMCI - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Treace Medical Concepts|TMCI - Company Aggregate Debts|Debt to Book Capitalization Ratio Treace Corp|TMCI - Company Long-Term Debt|Company Current Liabilities Treace Medical Concepts|Quick Ratio treace.com
- financial results and valuation multiples details:
TMCI - Company Net Income|Expected Profit Treace Medical Concepts|TMCI - Market Cap to Net Income Ratio|Projected Price to Earnings Treace Medical|TMCI - PEG Multiple|EV/EBITDA Multiple Treace Corp|TMCI - Operating income before deduction of amortization|Earnings per share for the last twelve months Treace Medical Concepts|TMCI - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months treace.com|TMCI - Net earnings per share growth this year|Earnings growth forecast for next year Treace Medical Concepts
- sales and revenue indicators:
Fundamental company analysis:TMCI (Treace Medical Concepts, Inc.)
This indicator compares the current market value of Treace Medical Concepts (TMCI) with projected revenue, allowing for an assessment of the premium paid for future cash flows. Analyzing the forward P/S ratio is critical to understanding the scalability of Lapiplasty disposable titanium implant sales, as this multiple reflects the market consensus regarding the expansion rate of the company's recurring margin.
Who Treace Medical Concepts competes with
Price-to-Projected Revenue Ratio Boston Scientific Corporation BSX|EW - Forward Price-to-Revenue Multiple|ResMed Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Insulet Inc.|ZBH: Forward P/S Multiple|Market Cap to Projected Revenue COO|ALGN (Align Technology) - Forward P/S Multiple|Globus Medical Inc (GMED) - Market Cap to Expected Sales Ratio|Forward P/S Multiple TMDX|Forward Price-to-Revenue Multiple Alphatec Corp ATEC|Forward P/S Multiple AORT (Artivion, Inc.)|Forward P/S Multiple enovis.com ENOV|IART - Price-to-Projected Revenue Ratio|ESTA: Price-to-Projected Revenue Ratio|BBNX (Beta Bionics Corp) - Forward Price-to-Revenue Multiple|IRADIMED Inc. - Forward Price to Sales|EMBC (Embecta Corp.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio tandemdiabetes.com TNDM|Price-to-Projected Revenue Ratio Axogen (AXGN)|SI-BONE Inc (SIBN) - Projected Price to Revenue|Orthofix International - Forward Price-to-Revenue Multiple|Forward P/S Multiple Bioventus Global BVS|OrthoPediatrics Inc. - Forward P/S Multiple|Market Cap to Expected Sales Ratio blade.com SRTA|Carlsmed (CARL) - Price-to-Projected Revenue Ratio|Future Price to Revenue RXST (RxSight Inc)|Price-to-Projected Revenue Ratio ClearPoint Neuro Inc.|Forward Price-to-Revenue Multiple Stereotaxis Corporation (STXS)|Forward P/S Multiple STIM|SGHT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Projected Revenue|NSPR: Forward Price-to-Revenue Multiple|Jin Medical International - Price to Expected Revenue Ratio|VANI (vivani.com) - Forward Price-to-Revenue Multiple|XTNT: Price to Expected Revenue Ratio|Price-to-Projected Revenue Ratio NeuroOne Medical Technologies Corporation|MODD: Forward Price to Sales|Forward P/S Multiple MYO|COCH - Market Cap to Future Revenue Ratio|Forward P/S Multiple VVOS (Vivos Therapeutics)|Forward P/S Multiple envveno.com NVNO|SINTX Technologies - Forward P/S Multiple|Tenon Medical Inc. (TNON) - Forward Price-to-Revenue Multiple|LFWD: Forward P/S Multiple|Market Cap to Future Revenue Ratio Autonomix Medical (AMIX)|Forward Price-to-Revenue Multiple IVF|BBLG: Forward Price to Sales|Price-to-Projected Revenue Ratio Axonics (AXNX)|Forward Price-to-Revenue Multiple BIOLASE Inc. BIOL|Forward P/S Multiple DYNT (Dynatronics)|Paragon 28 Inc. (FNA) - Market Cap to Future Revenue Ratio|INVO Bio - Forward P/S Multiple
